Prime Medicine, Inc. (PRME)
2.98
-0.01
(-0.33%)
USD |
NASDAQ |
Oct 02, 16:00
3.00
+0.02
(+0.67%)
After-Hours: 20:00
Prime Medicine Market Cap : 538.60M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 538.60M |
| October 01, 2026 | 540.41M |
| September 30, 2026 | 552.15M |
| September 29, 2026 | 558.48M |
| September 28, 2026 | 519.62M |
| September 25, 2026 | 524.14M |
| September 24, 2026 | 554.86M |
| September 23, 2026 | 565.71M |
| September 22, 2026 | 639.81M |
| September 21, 2026 | 576.55M |
| September 18, 2026 | 563.90M |
| September 17, 2026 | 567.52M |
| September 16, 2026 | 542.21M |
| September 15, 2026 | 567.52M |
| September 14, 2026 | 574.75M |
| September 11, 2026 | 565.71M |
| September 10, 2026 | 605.47M |
| September 09, 2026 | 627.16M |
| September 08, 2026 | 643.43M |
| September 04, 2026 | 668.73M |
| September 03, 2026 | 670.54M |
| September 02, 2026 | 663.31M |
| September 01, 2026 | 645.23M |
| August 31, 2026 | 648.85M |
| August 28, 2026 | 652.46M |
| Date | Value |
|---|---|
| August 27, 2026 | 657.88M |
| August 26, 2026 | 647.04M |
| August 25, 2026 | 670.54M |
| August 24, 2026 | 587.40M |
| August 21, 2026 | 612.70M |
| August 20, 2026 | 585.59M |
| August 19, 2026 | 639.81M |
| August 18, 2026 | 551.25M |
| August 17, 2026 | 572.94M |
| August 14, 2026 | 558.48M |
| August 13, 2026 | 572.94M |
| August 12, 2026 | 578.36M |
| August 11, 2026 | 589.20M |
| August 10, 2026 | 569.32M |
| August 07, 2026 | 556.67M |
| August 06, 2026 | 533.18M |
| August 05, 2026 | 556.67M |
| August 04, 2026 | 538.60M |
| August 03, 2026 | 507.53M |
| July 31, 2026 | 527.40M |
| July 30, 2026 | 545.46M |
| July 29, 2026 | 547.26M |
| July 28, 2026 | 558.10M |
| July 27, 2026 | 543.65M |
| July 24, 2026 | 532.82M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Beam Therapeutics, Inc. | 2.530B |
| Twist Bioscience Corp. | 11.82B |
| Intellia Therapeutics, Inc. | 1.717B |
| Q32 Bio, Inc. | 195.35M |
| Revolution Medicines, Inc. | 44.27B |
Market Cap Related Metrics
| PS Ratio | 127.19 |
| Price to Book Value | 13.53 |
| Price | 2.98 |
| Earnings Yield | -36.43% |